BBCIC Announces Major Milestone; Prepares for Comparative Effectiveness and Safety Studies of Biosimilars Coming to Market in 2017

Press Release: The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) this month reached a significant new phase of operation, posting research protocols that will lay the groundwork for comparative effectiveness and safety studies of biosimilars currently available or projected to enter the market next year.
Biosimilars